» Articles » PMID: 20660184

Additive Contribution of HLA Class I Alleles in the Immune Control of HIV-1 Infection

Overview
Journal J Virol
Date 2010 Jul 28
PMID 20660184
Citations 112
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies have identified a central role for HLA-B alleles in influencing control of HIV infection. An alternative possibility is that a small number of HLA-B alleles may have a very strong impact on HIV disease outcome, dominating the contribution of other HLA alleles. Here, we find that even following the exclusion of subjects expressing any of the HLA-B class I alleles (B*57, B*58, and B*18) identified to have the strongest influence on control, the dominant impact of HLA-B alleles on virus set point and absolute CD4 count variation remains significant. However, we also find that the influence of HLA on HIV control in this C-clade-infected cohort from South Africa extends beyond HLA-B as HLA-Cw type remains a significant predictor of virus and CD4 count following exclusion of the strongest HLA-B associations. Furthermore, there is evidence of interdependent protective effects of the HLA-Cw*0401-B*8101, HLA-Cw*1203-B*3910, and HLA-A*7401-B*5703 haplotypes that cannot be explained solely by linkage to a protective HLA-B allele. Analysis of individuals expressing both protective and detrimental alleles shows that even the strongest HLA alleles appear to have an additive rather than dominant effect on HIV control at the individual level. Finally, weak but significant frequency-dependent effects in this cohort can be detected only by looking at an individual's combined HLA allele frequencies. Taken together, these data suggest that although individual HLA alleles, particularly HLA-B, can have a strong impact, HIV control overall is likely to be influenced by the additive effect of some or all of the other HLA alleles present.

Citing Articles

High Resolution Class I , and - Diversity in Eastern and Southern African Populations.

Banjoko A, Nguni T, Naidoo N, Ramsuran V, Hyrien O, Ndhlovu Z bioRxiv. 2024; .

PMID: 39282263 PMC: 11398358. DOI: 10.1101/2024.09.04.611164.


Identification of a Clade-Specific HLA-C*03:02 CTL Epitope GY9 Derived from the HIV-1 p17 Matrix Protein.

Kyobe S, Mwesigwa S, Nkurunungi G, Retshabile G, Egesa M, Katagirya E Int J Mol Sci. 2024; 25(17).

PMID: 39273630 PMC: 11395705. DOI: 10.3390/ijms25179683.


Cross-population applications of genomics to understand the risk of multifactorial traits involving inflammation and immunity.

Alamad B, Elliott K, Knight J Camb Prism Precis Med. 2024; 2:e3.

PMID: 38549844 PMC: 10953767. DOI: 10.1017/pcm.2023.25.


Insights to HIV-1 coreceptor usage by estimating HLA adaptation with Bayesian generalized linear mixed models.

Hake A, Germann A, De Beer C, Thielen A, Daumer M, Preiser W PLoS Comput Biol. 2023; 19(12):e1010355.

PMID: 38127856 PMC: 10769057. DOI: 10.1371/journal.pcbi.1010355.


Africa-specific human genetic variation near CHD1L associates with HIV-1 load.

McLaren P, Porreca I, Iaconis G, Mok H, Mukhopadhyay S, Karakoc E Nature. 2023; 620(7976):1025-1030.

PMID: 37532928 PMC: 10848312. DOI: 10.1038/s41586-023-06370-4.


References
1.
Ngumbela K, Day C, Mncube Z, Nair K, Ramduth D, Thobakgale C . Targeting of a CD8 T cell env epitope presented by HLA-B*5802 is associated with markers of HIV disease progression and lack of selection pressure. AIDS Res Hum Retroviruses. 2008; 24(1):72-82. DOI: 10.1089/aid.2007.0124. View

2.
Dolan M, Kulkarni H, Camargo J, He W, Smith A, Anaya J . CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms. Nat Immunol. 2007; 8(12):1324-36. DOI: 10.1038/ni1521. View

3.
Smith M, Dean M, Carrington M, Winkler C, Huttley G, Lomb D . Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City.... Science. 1997; 277(5328):959-65. DOI: 10.1126/science.277.5328.959. View

4.
Kiepiela P, Leslie A, Honeyborne I, Ramduth D, Thobakgale C, Chetty S . Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature. 2004; 432(7018):769-75. DOI: 10.1038/nature03113. View

5.
Carrington M, OBrien S . The influence of HLA genotype on AIDS. Annu Rev Med. 2003; 54:535-51. DOI: 10.1146/annurev.med.54.101601.152346. View